We evaluated the intracellular expression of p62 in OPMDs and compared it with various clinical features, such as the malignant transformation of OPMDs, and biomarkers, such as Exportin-1 (XPO1), p53, and ki67, which are cancer-related factors. This evidence concerns the gene MKI67 and cancer.